Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 15 tags : Covid save search
COVID-19 Response
Published: 2021-11-15 (Crawled : 20:00) - tronox.com
TROX | $16.19 1.51% -1.48% 1.1M
|
Process Industries
|
| O: -0.49%
H: 0.23%
C: -1.11%
covid response covid-19
COVID-19 Vaccine Perspectives Survey Illustrates Importance of Physician-Patient Communication and Prioritization of Disability Community and their Caregivers in Public Health Campaigns
Published: 2021-11-15 (Crawled : 18:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.36%
H: 0.0%
C: 0.0%
covid communication vaccine
COVID Update: U.S. Exceeds 400 Million Vaccine Doses and Waning Efficacy
Published: 2021-11-15 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.36%
H: 0.0%
C: 0.0%
covid vaccine
Health Canada Authorizes Booster Dose of Moderna’s COVID-19 Vaccine in Individuals 18 Years of Age and Older
Published: 2021-11-15 (Crawled : 15:30) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.19%
H: 0.0%
C: 0.0%
covid vaccine order
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M
|
Health Technology
|
| O: -0.39%
H: 1.4%
C: -4.96%
covid disease antibody iot
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
RDHL | $0.4519 7.39% 6.88% 330K
|
Health Technology
|
| O: -2.83%
H: 0.0%
C: 0.0%
covid phase 2 biopharma ongoing phase 2/3
NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2
Published: 2021-11-15 (Crawled : 12:30) - biospace.com/
NNVC | $1.1 -6.38% 0.0% 22K
|
Health Technology
|
| O: 9.27%
H: 0.0%
C: 0.0%
covid drug
RedHill Biopharma Ltd Announces RedHill: LPI in Part A of RHB-107 P2/3 COVID Study
Published: 2021-11-15 (Crawled : 12:30) - biospace.com/
RDHL | $0.4519 7.39% 6.88% 330K
|
Health Technology
|
| O: -2.83%
H: 0.0%
C: 0.0%
covid biopharma
Cars.com Finds 84% of Travelers Will Drive This Thanksgiving Holiday, Steered by Flight Disruptions, Flexible Work Schedules and Lingering COVID-19 Concerns
Published: 2021-11-15 (Crawled : 12:00) - prnewswire.com
CARS | $16.44 1.67% 0.0% 340K
|
Technology Services
|
| O: 0.68%
H: 0.6%
C: -1.57%
covid travel
Adagio Therapeutics Provides Update for ADG20 COVID-19 Antibody Program and Reports Third Quarter 2021 Financial Results
Published: 2021-11-15 (Crawled : 12:00) - globenewswire.com
ADGI | $4.83 -1.45%
|
|
| O: 0.13%
H: 11.58%
C: 5.71%
covid financial results results antibody adg20
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.